Summary:
Allogeneic SCT remains the only potential cure for patients with thalassemia. However, most BMT candidates lack a suitable family donor and require an unrelated donor (UD). We evaluated whether BMT using UDs in high-risk adult thalassemia patients can offer a probability of cure comparable to that reported employing an HLA-compatible sibling as donor. A total of 27 adult thalassemia patients (15 males and 12 females, median age 22 years) underwent BMT from a UD selected by high-resolution HLA molecular typing. The conditioning regimen consisted of Busulphan (BU, 14 mg/kg) plus Cyclophosphamide (CY, 120 or 160 mg/kg) in 12 cases and BU (14 mg/kg), Thiotepa (10 mg/kg) and CY (120–160 mg/kg) in the remaining 15 cases. Cyclosporine-A and short-term Methotrexate were used for graft-versus-host disease (GVHD) prophylaxis. In all, 19 patients (70%) are alive and transfusion-independent after a median follow-up of 43 months (range 16–137). A total of 10 patients (37%) developed grade II–IV acute GVHD and six (27%) chronic GVHD. Eight patients (30%) died from transplant-related causes. UD-BMT can cure more than two-thirds of adult thalassemia patients, and is a particularly attractive option for patients who are not compliant with conventional treatment.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Modell B, Khan M, Darlison M . Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet 2000; 355: 2051–2052.
Olivieri NF . The β-Thalassemia. N Engl J Med 1999; 34: 99–109.
Borgna-Pignatti C, Rugolotto S, De Stefano P et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004; 89: 1187–1193.
Lucarelli G, Galimberti M, Polchi P et al. Bone marrow transplantation in patients with thalassemia. N Engl J Med 1990; 322: 417–421.
Lucarelli G, Galimberti M, Polchi P et al. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. N Engl J Med 1993; 329: 840–844.
Lucarelli G, Clift R, Galimberti M et al. Bone marrow transplantation in adult thalassemic patients. Blood 1999; 93: 1164–1167.
Anasetti C, Etzioni R, Petersdorf EW et al. Marrow transplantation from unrelated volunteer donors. Ann Rev Med 1995; 46: 169–179.
Sasazuki T, Juji T, Morishima Y et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. N Engl J Med 1998; 339: 1177–1193.
Petersdorf EW, Gooley TA, Anasetti C et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 1998; 92: 3515–3520.
La Nasa G, Giardini C, Argiolu F et al. Unrelated donor bone marrow transplantation for thalassemia: the effect of extended haplotypes. Blood 2002; 99: 4350–4356.
Cao A, Galanello R . Effect of consanguinity on screening for Thalassemia. N Engl J Med 2002; 347: 1200–1202.
Lucarelli G, Giardini C, Angelucci E . Bone Marrow Transplantation in thalassemia. In: Winter JN (ed.) Blood Stem Cell Transplantation. Kluwer Academic: Boston, 1997, pp 305–315.
Scheltinga SA, Johnston-Dow LA, White CB et al. A generic sequencing based typing approach for the identification of HLA-A diversity. Hum Immunol 1997; 57: 120–128.
Van Der Vlies SA, Voorter CEM, Van Den Berg-Loonen EM . A reliable and efficient high resolution typing method for HLA-C using sequence-based typing. Tissue Antigens 1998; 52: 558–568.
Voorter CEM, Rozemuller EH, De Bruyn-Geraets D et al. Comparison of DRB sequence-based typing using different strategies. Tissue Antigens 1997; 49: 471–476.
Bodmer JG, Marsh SG, Albert ED et al. Nomenclature for factors of the HLA System, 1998. Tissue Antigens 1999; 53: 407–446.
Thomas ED, Storb R, Clift RA et al. Bone marrow transplant. N Engl J Med 1975; 292: 832–843.
Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long-term clinico-pathologic study of 20 Seattle patients. Am J Med 1980; 69: 204–217.
Kaplan ER, Meier P . Non parametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457–481.
Hongeng S, Pakakasama S, Chaisiripoomkere W et al. Outcome of transplantation with unrelated donor bone marrow in children with severe thalassaemia. Bone Marrow Transplant 2004; 33: 377–379.
Sodani P, Gaziev D, Polchi P et al. A new approach for bone marrow transplantation in class 3 thalassemic patients aged less than 17 years. Blood 2004; 104: 1201–1203.
Acknowledgements
We thank Professor Guido Lucarelli for his precious comments and critical revision, Anna Maria Koopmans for her assistance in preparing the manuscript and the GITMO (Gruppo Italiano Trapianto Midollo Osseo) for supporting this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
La Nasa, G., Caocci, G., Argiolu, F. et al. Unrelated donor stem cell transplantation in adult patients with thalassemia. Bone Marrow Transplant 36, 971–975 (2005). https://doi.org/10.1038/sj.bmt.1705173
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705173
Keywords
This article is cited by
-
Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxin
Nature Biotechnology (2016)
-
Amelioration of murine sickle cell disease by nonablative conditioning and γ-globin gene-corrected bone marrow cells
Molecular Therapy - Methods & Clinical Development (2015)
-
Alternative donor transplant of benign primary hematologic disorders
Bone Marrow Transplantation (2015)
-
Unrelated Umbilical Cord Blood Transplant for Children with β-Thalassemia Major
Indian Journal of Hematology and Blood Transfusion (2015)
-
Ethical issues of unrelated hematopoietic stem cell transplantation in adult thalassemia patients
BMC Medical Ethics (2011)